Status:
RECRUITING
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Comprehensive Cancer Centre The Netherlands
Conditions:
Cancer
Dermatologic Conditions
Eligibility:
All Genders
3+ years
Brief Summary
The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer p...
Eligibility Criteria
Inclusion
- Cancer patients and survivors with a pre-existing dermatologic condition related to their underlying disease or completed/ongoing therapy for cancer, who present for assessment/management of their skin condition.
- Male or female patients at least 3 years and older
- NOTE: Informed Consent guidelines will be followed for minors
- First grade adult family members, spouses, and caregivers of patients with a Grade 2 or 3 or higher dermatologic condition related to their primary cancer or cancer treatment able to provide written informed consent
Exclusion
- Cognitive or psychiatric deficit resulting in an inability to provide written informed consent
Key Trial Info
Start Date :
November 18 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
1025 Patients enrolled
Trial Details
Trial ID
NCT02296450
Start Date
November 18 2014
End Date
November 1 2026
Last Update
December 19 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
2
Memorial Sloan Kettering Westchester
Harrison, New York, United States, 10604
3
Memorial Sloan Kettering Suffolk- Hauppauge
Hauppauge, New York, United States, 11788
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065